← All trials
NCT02726620
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2017
- Primary completion
- Jul 1, 2018
- Completion date
- Aug 1, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 16000
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- Vanderbilt UniversityLead sponsor
- Vanderbilt UniversityOverall official - principal investigator
- Utrecht UniversityCollaborator
- Vanderbilt UniversityReponsible party - principal investigator
Drugs studied
- ringer's lactate
- phenylephrine
- propofol
- tetracaine
- benzocaine
- norepinephrine
- isoflurane
- sevoflurane
- glycopyrronium
- albumin (Human)
- ephedrine
- chloroprocaine
- mepivacaine
- ropivacaine
- lidocaine
- epinephrine
- red blood cells
- levobupivacaine
- desflurane
- articaine
- terlipressin
- atropine
- dobutamine
- vasopressin
- blood plasma
- procaine merethoxylline
- sodium chloride
- milrinone
- dopamine
- prilocaine
- isoprenaline
- hydroxyethyl starch
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.